Status:
RECRUITING
Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Urinary Tract Infections
Urinary Tract Infections in Children
Eligibility:
All Genders
3-3 years
Brief Summary
The emergence of extended-spectrum beta-lactamase-producing Enterobacteriaceae (E-ESBL) is a major public health problem. It leads more frequent prescription of penems with the risk of emergence and s...
Eligibility Criteria
Inclusion
- Infant and child (age ≥ 3 months and \<3 years)
- Patient treated for febrile urinary tract infection as monotherapy with amikacin IV, ceftriaxone (IV or IM) or cefixime PO \*
- Whose parents read and understood the newsletter and whose express consent was collected
- Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
Exclusion
- Child treated with more than one antibiotic (eg treatment with dual therapy ceftriaxone / cefotaxime and aminoglycoside)
- Antibiotherapy in progress or discontinued in the previous 7 days
- Hospitalized child
- Refusal of one of the parents
Key Trial Info
Start Date :
January 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03825874
Start Date
January 19 2019
End Date
July 1 2026
Last Update
August 27 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet du Dr Benali
Charenton-le-Pont, France, 94220
2
Cabinet du Dr Coicadan
Chennevières-sur-Marne, France, 94430
3
Cabinet du Dr Corrard
Combs-la-Ville, France, 77380
4
Cabinet du Dr Thollot
Essey-lès-Nancy, France, 54270